vs
Lovesac Co（LOVE）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Lovesac Co的季度营收约是再鼎医药的1.2倍（$150.2M vs $127.1M），再鼎医药同比增速更快（17.1% vs 0.2%），Lovesac Co自由现金流更多（$-10.2M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -22.6%）
Lovesac是美国的家具零售商，主打拥有专利的Sactionals模块化沙发系统，该系统由可自由组合的座部、侧部模块，以及定制沙发套和相关配件组成。除模块化沙发外，品牌还销售采用独家发泡混合材料填充的袋式懒人座椅。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
LOVE vs ZLAB — 直观对比
营收规模更大
LOVE
是对方的1.2倍
$127.1M
营收增速更快
ZLAB
高出16.9%
0.2%
自由现金流更多
LOVE
多$16.5M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-22.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.2M | $127.1M |
| 净利润 | $-10.6M | — |
| 毛利率 | 56.1% | 51.0% |
| 营业利润率 | -10.5% | -54.6% |
| 净利率 | -7.0% | — |
| 营收同比 | 0.2% | 17.1% |
| 净利润同比 | -114.0% | — |
| 每股收益（稀释后） | $-0.72 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LOVEZLAB
| Q4 25 | $150.2M | $127.1M | ||
| Q3 25 | $160.5M | $115.4M | ||
| Q2 25 | $138.4M | $109.1M | ||
| Q1 25 | $241.5M | $105.7M | ||
| Q4 24 | $149.9M | $108.5M | ||
| Q3 24 | $156.6M | $101.8M | ||
| Q2 24 | $132.6M | $100.1M | ||
| Q1 24 | $250.5M | $87.1M |
净利润LOVEZLAB
| Q4 25 | $-10.6M | — | ||
| Q3 25 | $-6.7M | $-36.0M | ||
| Q2 25 | $-10.8M | $-40.7M | ||
| Q1 25 | $35.3M | $-48.4M | ||
| Q4 24 | $-4.9M | — | ||
| Q3 24 | $-5.9M | $-41.7M | ||
| Q2 24 | $-13.0M | $-80.3M | ||
| Q1 24 | $31.0M | $-53.5M |
毛利率LOVEZLAB
| Q4 25 | 56.1% | 51.0% | ||
| Q3 25 | 56.4% | 59.5% | ||
| Q2 25 | 53.7% | 60.6% | ||
| Q1 25 | 60.4% | 63.6% | ||
| Q4 24 | 58.5% | 61.5% | ||
| Q3 24 | 59.0% | 64.1% | ||
| Q2 24 | 54.3% | 64.9% | ||
| Q1 24 | 59.7% | 61.4% |
营业利润率LOVEZLAB
| Q4 25 | -10.5% | -54.6% | ||
| Q3 25 | -5.5% | -42.3% | ||
| Q2 25 | -10.8% | -50.3% | ||
| Q1 25 | 19.7% | -53.3% | ||
| Q4 24 | -5.2% | -62.6% | ||
| Q3 24 | -5.3% | -66.6% | ||
| Q2 24 | -13.5% | -76.0% | ||
| Q1 24 | 16.1% | -80.7% |
净利率LOVEZLAB
| Q4 25 | -7.0% | — | ||
| Q3 25 | -4.1% | -31.2% | ||
| Q2 25 | -7.8% | -37.3% | ||
| Q1 25 | 14.6% | -45.8% | ||
| Q4 24 | -3.3% | — | ||
| Q3 24 | -3.7% | -40.9% | ||
| Q2 24 | -9.8% | -80.2% | ||
| Q1 24 | 12.4% | -61.4% |
每股收益（稀释后）LOVEZLAB
| Q4 25 | $-0.72 | $-0.05 | ||
| Q3 25 | $-0.45 | $-0.03 | ||
| Q2 25 | $-0.73 | $-0.04 | ||
| Q1 25 | $2.22 | $-0.04 | ||
| Q4 24 | $-0.32 | $-0.09 | ||
| Q3 24 | $-0.38 | $-0.04 | ||
| Q2 24 | $-0.83 | $-0.08 | ||
| Q1 24 | $1.91 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.7M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $189.3M | $715.5M |
| 总资产 | $495.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LOVEZLAB
| Q4 25 | $23.7M | $689.6M | ||
| Q3 25 | $34.2M | $717.2M | ||
| Q2 25 | $26.9M | $732.2M | ||
| Q1 25 | $83.7M | $757.3M | ||
| Q4 24 | $61.7M | $779.7M | ||
| Q3 24 | $72.1M | $616.1M | ||
| Q2 24 | $72.4M | $630.0M | ||
| Q1 24 | $87.0M | $650.8M |
股东权益LOVEZLAB
| Q4 25 | $189.3M | $715.5M | ||
| Q3 25 | $197.5M | $759.9M | ||
| Q2 25 | $201.2M | $791.7M | ||
| Q1 25 | $216.4M | $810.8M | ||
| Q4 24 | $196.5M | $840.9M | ||
| Q3 24 | $202.1M | $667.7M | ||
| Q2 24 | $205.3M | $704.2M | ||
| Q1 24 | $217.5M | $762.2M |
总资产LOVEZLAB
| Q4 25 | $495.5M | $1.2B | ||
| Q3 25 | $493.7M | $1.2B | ||
| Q2 25 | $483.7M | $1.2B | ||
| Q1 25 | $532.3M | $1.2B | ||
| Q4 24 | $499.7M | $1.2B | ||
| Q3 24 | $481.1M | $985.3M | ||
| Q2 24 | $477.2M | $987.4M | ||
| Q1 24 | $482.2M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-10.2M | $-26.7M |
| 自由现金流率自由现金流/营收 | -6.8% | -21.0% |
| 资本支出强度资本支出/营收 | 3.5% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流LOVEZLAB
| Q4 25 | $-4.9M | $-26.0M | ||
| Q3 25 | $12.2M | $-32.0M | ||
| Q2 25 | $-41.4M | $-31.0M | ||
| Q1 25 | $44.0M | $-61.7M | ||
| Q4 24 | $-4.2M | $-55.8M | ||
| Q3 24 | $6.2M | $-26.8M | ||
| Q2 24 | $-7.0M | $-42.2M | ||
| Q1 24 | $56.3M | $-90.1M |
自由现金流LOVEZLAB
| Q4 25 | $-10.2M | $-26.7M | ||
| Q3 25 | $7.8M | $-35.0M | ||
| Q2 25 | $-50.0M | $-33.9M | ||
| Q1 25 | $38.7M | $-63.2M | ||
| Q4 24 | $-6.6M | $-58.4M | ||
| Q3 24 | $119.0K | $-28.2M | ||
| Q2 24 | $-14.3M | $-42.9M | ||
| Q1 24 | $49.5M | $-91.1M |
自由现金流率LOVEZLAB
| Q4 25 | -6.8% | -21.0% | ||
| Q3 25 | 4.9% | -30.4% | ||
| Q2 25 | -36.1% | -31.1% | ||
| Q1 25 | 16.0% | -59.9% | ||
| Q4 24 | -4.4% | -53.8% | ||
| Q3 24 | 0.1% | -27.7% | ||
| Q2 24 | -10.8% | -42.9% | ||
| Q1 24 | 19.8% | -104.5% |
资本支出强度LOVEZLAB
| Q4 25 | 3.5% | 0.5% | ||
| Q3 25 | 2.7% | 2.6% | ||
| Q2 25 | 6.2% | 2.6% | ||
| Q1 25 | 2.2% | 1.5% | ||
| Q4 24 | 1.6% | 2.4% | ||
| Q3 24 | 3.9% | 1.3% | ||
| Q2 24 | 5.5% | 0.7% | ||
| Q1 24 | 2.7% | 1.1% |
现金转化率LOVEZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOVE
| Showrooms | $102.7M | 68% |
| Internet | $37.3M | 25% |
| Other | $10.2M | 7% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
